ANTIMICROBIAL COMPOSITIONS AND METHODS
Antimicrobial compositions for killing or deactivating microbes, such as viruses, bacteria, or fungi, include metal nanoparticles, a carrier, and a plurality of metal nanoparticles. The nanoparticles can be selected to have a particle size and particle size distribution to selectively and preferentially kill one of a virus, a bacterium, or a fungus. Antiviral compositions can include nanoparticles having a particle size of 8 nm or less, 1-7 nm, 2-6.5 nm, or 3-6 nm (or up to 10 nm for Ebola virus). Antibacterial compositions can include nanoparticles having a particle size of 3-14 nm, 5-13 nm, 7-12 nm, or 8-10 nm. Antifungal compositions can include nanoparticles having a particle size of 9-20 nm, 10-18 nm, 11-16 nm, or 12-15 nm. Exemplary methods of killing or deactivating microbes include: (1) applying an antimicrobial composition to a substrate containing microbes, and (2) the antimicrobial composition killing or deactivating the microbes.
1 . A method of selectively killing or deactivating a target microbe, comprising:
applying an antimicrobial composition to the target microbe or to a substrate containing the target microbe, the antimicrobial composition comprising:
a carrier; and
a plurality of spherical-shaped, nonionic metal nanoparticles formed by laser ablation having a mean diameter in a range of 1-20 nm so as to selectively kill or deactivate the target microbe, wherein at least 99% of the spherical metal nanoparticles have a diameter within ±3 nm of the mean diameter; and
the antimicrobial composition selectively killing or deactivating the target microbe, which is selected from a bacterium, a virus, or a fungus, and wherein:
when the microbe is a bacterium the metal nanoparticles have a mean diameter in a range of 3 nm to 14 nm to selectively kill the bacterium,
when the microbe is a virus the metal nanoparticles have a mean diameter in a range of 1 nm to 7 nm to selectively kill the virus, or
when the microbe is a fungus the metal nanoparticles have a mean diameter in a range of 9 nm to 20 nm to selectively kill the fungus.
2 . The method of claim 1 , wherein the substrate is a non-living object.
3 . The method of claim 1 , wherein the substrate is a living organism.
4 . The method of claim 1 , wherein the microbe is a bacterium and the metal nanoparticles have a mean diameter in a range of 5 nm to 13 nm to selectively kill the bacterium.
5 . The method of claim 1 , wherein the microbe is a bacterium and the metal nanoparticles have a mean diameter in a range of 7 nm to 12 nm to selectively kill the bacterium.
6 . The method of claim 1 , wherein the microbe is a bacterium and the metal nanoparticles have a mean diameter in a range of 8 nm to 10 nm to selectively kill the bacterium.
7 . The method of claim 1 , wherein the microbe is a virus and the metal nanoparticles have a mean diameter in a range of 2 nm to 6.5 nm to selectively kill the virus.
8 . The method of claim 1 , wherein the microbe is a virus and the metal nanoparticles have a mean diameter in a range of 3 nm to 6 nm to selectively kill the virus.
9 . The method of claim 1 , wherein the microbe is a fungus and the metal nanoparticles have a mean diameter in a range of 10 nm to 18 nm to selectively kill the fungus.
10 . The method of claim 1 , wherein the microbe is a fungus and the metal nanoparticles have a mean diameter in a range of 11 nm to 16 nm to selectively kill the fungus.
11 . The method of claim 1 , wherein the microbe is a fungus and the metal nanoparticles have a mean diameter in a range of 12 nm to 15 nm to selectively kill the fungus.
12 . The method of claim 1 , wherein at least 99% of the spherical metal nanoparticles have a diameter within ±1 nm of the mean diameter.
13 . The method of claim 1 , wherein the antimicrobial composition further comprises coral-shaped metal nanoparticles, each coral-shaped metal nanoparticle having a non-uniform cross section and a globular structure formed by multiple, non-linear strands joined together without right angles.
14 . The method of claim 1 , wherein the carrier is a liquid in which the metal nanoparticles are colloidally dispersed.
15 . The method of claim 1 , wherein the metal nanoparticles have a concentration in a range of about 10 ppb to about 100 ppm by weight of the antimicrobial composition.
16 . The method of claim 1 , wherein the metal nanoparticles have a concentration in a range of about 100 ppb to about 75 ppm by weight of the antimicrobial composition.
17 . The method of claim 1 , wherein the metal nanoparticles have a concentration in a range of about 1 ppm to about 50 ppm by weight of the antimicrobial composition.
18 . The method of claim 1 , wherein the spherical metal nanoparticles comprise silver, gold, or an alloy of silver and gold.
19 . A method of selectively killing or deactivating a bacterium, comprising:
applying an antimicrobial composition to the bacterium or to a substrate containing the bacterium, the antimicrobial composition comprising:
a carrier; and
a plurality of spherical-shaped, nonionic metal nanoparticles formed from silver or a silver alloy and having a mean particle size in a range of 3-14 nm to selectively kill or deactivate the bacterium, wherein at least 99% of the spherical metal nanoparticles have a particle size within ±3 nm of the mean particle size; and
the antimicrobial composition selectively killing or deactivating the bacterium without release of silver ions.
20 . A method of selectively killing or deactivating a virus, comprising:
applying an antimicrobial composition to the virus or to a substrate containing the virus, the antimicrobial composition comprising:
a carrier; and
a plurality of spherical-shaped, nonionic metal nanoparticles formed from silver or a silver alloy and having a mean particle size in a range of 1-7 nm to selectively kill or deactivate the virus, wherein at least 99% of the spherical metal nanoparticles have a particle size within ±1 nm of the mean particle size; and
the antimicrobial composition selectively killing or deactivating the virus without release of silver ions.